Gilvetmab

Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.

Forte VII™

NEWHATCH-C2™

For the vaccination of healthy chickens 1-day of age against Newcastle disease.

AMOXI-MAST®

Treatment for subclinical infectious bovine mastitis in lactating cows due to Streptococcus agalactiae and penicillin-sensitive Staphylococcus aureus.